MX22863A - Procedimiento de preparacion de nuevos derivados sustituidos en posicion 15 de la 20,21-dinoreburnamenina. - Google Patents
Procedimiento de preparacion de nuevos derivados sustituidos en posicion 15 de la 20,21-dinoreburnamenina.Info
- Publication number
- MX22863A MX22863A MX2286390A MX2286390A MX22863A MX 22863 A MX22863 A MX 22863A MX 2286390 A MX2286390 A MX 2286390A MX 2286390 A MX2286390 A MX 2286390A MX 22863 A MX22863 A MX 22863A
- Authority
- MX
- Mexico
- Prior art keywords
- optionally substituted
- radical
- carbon atoms
- alkenyl
- alkyl
- Prior art date
Links
- 125000004432 carbon atom Chemical group C* 0.000 abstract 7
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 5
- 125000003342 alkenyl group Chemical group 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- JEVCWSUVFOYBFI-UHFFFAOYSA-N cyanyl Chemical compound N#[C] JEVCWSUVFOYBFI-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- BLNWTAHYTCHDJH-UHFFFAOYSA-O hydroxy(oxo)azanium Chemical compound O[NH+]=O BLNWTAHYTCHDJH-UHFFFAOYSA-O 0.000 abstract 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-M oxidooxomethyl Chemical compound [O-][C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-M 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Cephalosporin Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8913544A FR2653124B1 (fr) | 1989-10-17 | 1989-10-17 | Nouveaux derives substitues en 15 de la 20, 21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX22863A true MX22863A (es) | 1993-11-01 |
Family
ID=9386471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2286390A MX22863A (es) | 1989-10-17 | 1990-10-16 | Procedimiento de preparacion de nuevos derivados sustituidos en posicion 15 de la 20,21-dinoreburnamenina. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6534515B2 (es) |
| EP (1) | EP0424248B1 (es) |
| JP (1) | JPH03133981A (es) |
| KR (1) | KR0180706B1 (es) |
| CN (1) | CN1040000C (es) |
| AT (1) | ATE132867T1 (es) |
| AU (1) | AU646817B2 (es) |
| CA (1) | CA2027724A1 (es) |
| DE (1) | DE69024745T2 (es) |
| DK (1) | DK0424248T3 (es) |
| ES (1) | ES2081957T3 (es) |
| FR (1) | FR2653124B1 (es) |
| GR (1) | GR3018736T3 (es) |
| HU (1) | HU218937B (es) |
| IE (1) | IE71209B1 (es) |
| MX (1) | MX22863A (es) |
| PT (1) | PT95600B (es) |
| RU (1) | RU2069663C1 (es) |
| ZA (1) | ZA907832B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2865649A1 (fr) * | 2004-01-30 | 2005-08-05 | Biocortech | Utilisation du 14,15-dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures |
| FR2865650B1 (fr) * | 2004-01-30 | 2008-06-13 | Biocortech | Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR22021E (fr) * | 1919-12-30 | 1921-04-21 | Dujardin Et Cie | Perfectionnements aux frappeurs pneumatiques |
| AU532001B2 (en) * | 1978-11-20 | 1983-09-15 | Sumitomo Chemical Company, Limited | Polycyclic indole derivatives |
| FR2514357A1 (fr) * | 1981-10-08 | 1983-04-15 | Roussel Uclaf | Nouveaux derives de 20,21-dinoreburnamenine eventuellement substitues sur le cycle e, procede de preparation et application comme medicaments |
| FR2623501B1 (fr) * | 1987-11-19 | 1990-03-16 | Roussel Uclaf | Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
| FR2623503B1 (es) * | 1987-11-19 | 1991-04-05 | Roussel Uclaf |
-
1989
- 1989-10-17 FR FR8913544A patent/FR2653124B1/fr not_active Expired - Fee Related
-
1990
- 1990-10-01 ZA ZA907832A patent/ZA907832B/xx unknown
- 1990-10-16 CA CA002027724A patent/CA2027724A1/fr not_active Abandoned
- 1990-10-16 AT AT90402898T patent/ATE132867T1/de not_active IP Right Cessation
- 1990-10-16 EP EP90402898A patent/EP0424248B1/fr not_active Expired - Lifetime
- 1990-10-16 DE DE69024745T patent/DE69024745T2/de not_active Expired - Fee Related
- 1990-10-16 HU HU462/90A patent/HU218937B/hu not_active IP Right Cessation
- 1990-10-16 PT PT95600A patent/PT95600B/pt not_active IP Right Cessation
- 1990-10-16 IE IE370290A patent/IE71209B1/en not_active IP Right Cessation
- 1990-10-16 MX MX2286390A patent/MX22863A/es unknown
- 1990-10-16 ES ES90402898T patent/ES2081957T3/es not_active Expired - Lifetime
- 1990-10-16 DK DK90402898.2T patent/DK0424248T3/da active
- 1990-10-17 JP JP2276590A patent/JPH03133981A/ja active Pending
- 1990-10-17 KR KR1019900016818A patent/KR0180706B1/ko not_active Expired - Fee Related
- 1990-10-17 AU AU64668/90A patent/AU646817B2/en not_active Ceased
- 1990-10-17 CN CN90108428A patent/CN1040000C/zh not_active Expired - Fee Related
-
1992
- 1992-01-22 RU SU5010658/04A patent/RU2069663C1/ru not_active IP Right Cessation
-
1994
- 1994-04-15 US US08/228,300 patent/US6534515B2/en not_active Expired - Fee Related
-
1996
- 1996-01-19 GR GR950401768T patent/GR3018736T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE71209B1 (en) | 1997-02-12 |
| KR910007930A (ko) | 1991-05-30 |
| AU646817B2 (en) | 1994-03-10 |
| IE903702A1 (en) | 1991-04-24 |
| AU6466890A (en) | 1991-04-26 |
| RU2069663C1 (ru) | 1996-11-27 |
| EP0424248B1 (fr) | 1996-01-10 |
| CA2027724A1 (fr) | 1991-04-18 |
| CN1040000C (zh) | 1998-09-30 |
| DE69024745D1 (de) | 1996-02-22 |
| KR0180706B1 (ko) | 1999-03-20 |
| DE69024745T2 (de) | 1996-11-14 |
| JPH03133981A (ja) | 1991-06-07 |
| FR2653124A1 (fr) | 1991-04-19 |
| HU218937B (hu) | 2001-01-29 |
| ES2081957T3 (es) | 1996-03-16 |
| PT95600A (pt) | 1991-09-13 |
| US6534515B2 (en) | 2003-03-18 |
| DK0424248T3 (da) | 1996-03-04 |
| GR3018736T3 (en) | 1996-04-30 |
| ATE132867T1 (de) | 1996-01-15 |
| US20020045637A1 (en) | 2002-04-18 |
| HU906462D0 (en) | 1991-04-29 |
| ZA907832B (en) | 1991-12-24 |
| PT95600B (pt) | 1997-08-29 |
| EP0424248A3 (en) | 1992-01-22 |
| EP0424248A2 (fr) | 1991-04-24 |
| FR2653124B1 (fr) | 1992-01-17 |
| CN1051042A (zh) | 1991-05-01 |
| HUT55013A (en) | 1991-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2066875T3 (es) | Aminoalquilindoles, procedimiento para su obtencion y preparados farmaceuticos que los contienen. | |
| MX9204029A (es) | Procedimiento de preparacion de un derivado de la bacatina iii y de la 10-desacetil bacatina iii | |
| ES8303291A1 (es) | Un procedimiento para la preparacion de nuevos derivados de ariletanolamina. | |
| DE3069813D1 (en) | Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation | |
| ZA9010412B (en) | 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their application in therapeutics | |
| ATE100103T1 (de) | 1,8-benzonaphthyridinderivate, ihre herstellung und diese enthaltende zusammensetzungen. | |
| EP0351255A3 (en) | Derivatives of û2-(4-piperidinyl)methyl¨-1,2,3,4-tetrahydroisoquinoline, their preparation and their use in therapy | |
| MX22863A (es) | Procedimiento de preparacion de nuevos derivados sustituidos en posicion 15 de la 20,21-dinoreburnamenina. | |
| ATE43575T1 (de) | (4.2.0>-bicyclooctanderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| MX19565A (es) | Nuevos derivados de 1-arilsulfonil-2-piperidinona y procedimiento para su preparacion | |
| DE68918832D1 (de) | Benzoxazepinderivate. | |
| DE3862660D1 (de) | 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel. | |
| MX11976A (es) | Procedimiento para preparar derivados de 1-benzoil-2-oxo-5-alcoxi-pirrolidina y producto obtenido. | |
| ATE53839T1 (de) | 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| PT84172B (pt) | Processo para a preparacao de derivados da quinoleina | |
| HUT50833A (en) | Process for producing indolo/3,2-1-de/ /1,4/-oxazino/2,3,4-ij/ /1,5/-naphthyridine derivatives | |
| SE8600411D0 (sv) | Isokinolinderivat, deras framstellning och anvendning | |
| IT1244649B (it) | Procedimento per il trattamento di substrati com composti aromatici contenenti gruppi solfo, composizioni contenenti tali composti e loro preparazione |